1. Home
  2. BLRX vs KTCC Comparison

BLRX vs KTCC Comparison

Compare BLRX & KTCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • KTCC
  • Stock Information
  • Founded
  • BLRX 2003
  • KTCC 1969
  • Country
  • BLRX Israel
  • KTCC United States
  • Employees
  • BLRX N/A
  • KTCC N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • KTCC Electrical Products
  • Sector
  • BLRX Health Care
  • KTCC Technology
  • Exchange
  • BLRX Nasdaq
  • KTCC Nasdaq
  • Market Cap
  • BLRX 36.0M
  • KTCC 61.1M
  • IPO Year
  • BLRX 2011
  • KTCC N/A
  • Fundamental
  • Price
  • BLRX $0.20
  • KTCC $3.97
  • Analyst Decision
  • BLRX Strong Buy
  • KTCC
  • Analyst Count
  • BLRX 2
  • KTCC 0
  • Target Price
  • BLRX $5.50
  • KTCC N/A
  • AVG Volume (30 Days)
  • BLRX 1.7M
  • KTCC 39.5K
  • Earning Date
  • BLRX 11-25-2024
  • KTCC 02-04-2025
  • Dividend Yield
  • BLRX N/A
  • KTCC N/A
  • EPS Growth
  • BLRX N/A
  • KTCC N/A
  • EPS
  • BLRX N/A
  • KTCC N/A
  • Revenue
  • BLRX $21,991,000.00
  • KTCC $548,388,000.00
  • Revenue This Year
  • BLRX N/A
  • KTCC N/A
  • Revenue Next Year
  • BLRX N/A
  • KTCC N/A
  • P/E Ratio
  • BLRX N/A
  • KTCC N/A
  • Revenue Growth
  • BLRX N/A
  • KTCC N/A
  • 52 Week Low
  • BLRX $0.19
  • KTCC $3.60
  • 52 Week High
  • BLRX $1.68
  • KTCC $6.14
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 25.94
  • KTCC 14.86
  • Support Level
  • BLRX $0.23
  • KTCC $5.30
  • Resistance Level
  • BLRX $0.56
  • KTCC $5.75
  • Average True Range (ATR)
  • BLRX 0.03
  • KTCC 0.19
  • MACD
  • BLRX 0.00
  • KTCC -0.13
  • Stochastic Oscillator
  • BLRX 11.82
  • KTCC 0.00

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About KTCC Key Tronic Corporation

Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.

Share on Social Networks: